New York State Common Retirement Fund
ADMA icon

New York State Common Retirement Fund’s ADMA Biologics ADMA Stock Holding History

New York State Common Retirement Fund’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$598K Sell
71,497
-76,877
-52% -$701K ﹤0.01% 1932
2026
Q1 		$1.34M Buy
148,374
+2,934
+2% +$46.3K ﹤0.01% 1551
2025
Q4 		$2.65M Buy
145,440
+30,936
+27% +$521K ﹤0.01% 1292
2025
Q3 		$1.68M Sell
114,504
-198,337
-63% -$3.4M ﹤0.01% 1493
2025
Q2 		$5.7M Buy
312,841
+38,422
+14% +$783K 0.01% 1017
2025
Q1 		$5.44M Buy
274,419
+30,400
+12% +$526K 0.01% 1011
2024
Q4 		$4.18M Sell
244,019
-11,550
-5% -$217K 0.01% 1162
2024
Q3 		$5.11M Buy
255,569
+7,872
+3% +$122K 0.01% 1094
2024
Q2 		$2.77M Buy
247,697
+11,577
+5% +$97.1K ﹤0.01% 1349
2024
Q1 		$1.56M Buy
236,120
+149,468
+172% +$817K ﹤0.01% 1572
2023
Q4 		$392K Buy
86,652
+24,033
+38% +$88.9K ﹤0.01% 2193
2023
Q3 		$224K Buy
62,619
+571
+0.9% +$2.2K ﹤0.01% 2376
2023
Q2 		$229K Sell
62,048
-30,055
-33% -$111K ﹤0.01% 2433
2023
Q1 		$305K Sell
92,103
-37,727
-29% -$130K ﹤0.01% 2423
2022
Q4 		$504K Sell
129,830
-170
-0.1% -$524 ﹤0.01% 2307
2022
Q3 		$316K Buy
130,000
+1,700
+1% +$4.08K ﹤0.01% 2565
2022
Q2 		$254K Buy
+128,300
New +$252K ﹤0.01% 2685
2021
Q3 		– Sell
-478
Closed -$1K – 3328
2021
Q2 		$1K Sell
478
-40,022
-99% -$70.4K ﹤0.01% 3357
2021
Q1 		$71K Hold
40,500
– – ﹤0.01% 3149
2020
Q4 		$79K Hold
40,500
– – ﹤0.01% 3110
2020
Q3 		$97K Hold
40,500
– – ﹤0.01% 2931
2020
Q2 		$119K Hold
40,500
– – ﹤0.01% 2862
2020
Q1 		$117K Hold
40,500
– – ﹤0.01% 2703
2019
Q4 		$162K Hold
40,500
– – ﹤0.01% 2822
2019
Q3 		$180K Buy
40,500
+37,900
+1,458% +$158K ﹤0.01% 2823
2019
Q2 		$10K Hold
2,600
– – ﹤0.01% 3228
2019
Q1 		$10K Hold
2,600
– – ﹤0.01% 3148
2018
Q4 		$6K Sell
2,600
-18,500
-88% -$91.6K ﹤0.01% 3178
2018
Q3 		$131K Hold
21,100
– – ﹤0.01% 2994
2018
Q2 		$95K Buy
+21,100
New +$105K ﹤0.01% 3093

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

New York State Common Retirement Fund's ADMA Position: Q2 2026 in Review

New York State Common Retirement Fund reduced its ADMA Biologics (ADMA) stake by 52% in Q2 2026, selling an estimated $701K and leaving 71,497 shares worth $598K. The position accounts for ﹤0.01% of the portfolio, ranked #1932.

New York State Common Retirement Fund first reported a position in ADMA in Q2 2018 and has held it in 30 quarters since. The position peaked at $5.7M in Q2 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • New York State Common Retirement Fund held 71,497 shares of ADMA Biologics worth $598K as of Q2 2026.
  • New York State Common Retirement Fund sold 76,877 ADMA Biologics shares in Q2 2026, an estimated $701K.
  • ADMA Biologics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1932 holding.
  • New York State Common Retirement Fund first reported a position in ADMA Biologics in Q2 2018 and has held it in 30 quarters since.
  • New York State Common Retirement Fund's ADMA Biologics position peaked at $5.7M in Q2 2025.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.